Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLGW) Free Cash Flow (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Free Cash Flow for 2 consecutive years, with -$931700.0 as the latest value for Q4 2017.

  • Quarterly Free Cash Flow rose 26.51% to -$931700.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$3.3 million through Dec 2017, up 54.56% year-over-year, with the annual reading at -$2.7 million for FY2025, 34.54% up from the prior year.
  • Free Cash Flow for Q4 2017 was -$931700.0 at Bone Biologics, down from -$561035.0 in the prior quarter.
  • The five-year high for Free Cash Flow was -$561035.0 in Q3 2017, with the low at -$2.5 million in Q1 2016.